Why Is HEARTFLOW INC (HTFL) Stock Up Today?

HeartFlow Inc (HTFL) shares rose 6.90% to $27.25 on Tuesday, driven by a surge in institutional optimism and recent guidance updates. The stock is responding to a cluster of positive analyst ratings and an upward revision in full-year sales projections. Despite ongoing losses, the company's growing revenue and improving sentiment have fueled a sharp intraday rebound.

What Happened

HeartFlow's CEO, John C.M. Farquhar, has sold shares on three separate occasions since June 2026, most recently on July 10. This activity has raised questions among investors, but the broader market appears focused on the company's recent developments. Institutional analysts have reinforced their bullish stance, with Freedom Capital Markets initiating coverage with a Buy rating and a $37 price target. Canaccord Genuity and Wells Fargo also maintain Buy or Overweight ratings, with both raising or maintaining their $37 price targets. In addition, HeartFlow raised its FY2026 sales guidance from $218 million to $228 million, signaling stronger demand for its diagnostic solutions.

What The Data Shows

HeartFlow has a market cap of $2.3 billion and remains unprofitable with a trailing twelve-month (TTM) EPS of -1.97. However, revenue has grown by 40.6% TTM, and the stock is currently trading within its 52-week range of $20.13 to $41.22. The stock has seen a 7-day sentiment improvement, with the score rising to 61 out of 100 from 56. Institutional activity has outpaced retail selling, with no insider buys reported in the last 90 days but four sales totaling $3.3 million.

What To Watch

Investors should monitor the Q1 2026 earnings call transcript and the company's ability to meet the new sales guidance. The stock remains underpinned by strong analyst coverage and a positive trajectory in revenue growth.